EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

The Prognostic Role of miR-375 in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis

Mario Dioguardi iD, Gennaro Musella iD, Maria Eleonora Bizzoca, Diego Sovereto, Ciro Guerra, Pietro Laterza iD, Angelo Martella iD, Lorenzo Lo Muzio iD, Marina Di Domenico, Stefania Cantore iD, Andrea Ballini iD

International Journal of Molecular Sciences · 28.02.2025 · 26 (5) · 2183

DOI: 10.3390/ijms26052183 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.02.2025. Verfasst von Mario Dioguardi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122 Foggia, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Squamous Cell Carcinoma of Head and Neck, Biomarkers, Tumor, Head and Neck Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGeneration EU, PNRR - M4C2-I1.3"HEALTH EXTENDED ALLIANCE FOR INNOVATIVE THERAPIES, AD-VANCED LAB-RE-SEARCH, AND INTEGRATED APPROACHES OF PRE…, European Union-NextGeneration EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and Neck Squamous Cell Carcinoma (HNSCC) is a heterogeneous group of malignancies with poor survival outcomes, particularly in advanced stages. Identifying prognostic biomarkers could help improve patient management. miR-375, a small non-coding RNA, has been shown to influence tumor growth and immune responses, making it a candidate biomarker. This study aims to evaluate the role of miR-375 expression in predicting survival outcomes in HNSCC patients. A systematic review and meta-analysis were conducted according to PRISMA guidelines, incorporating data from six studies and the TGCA cohort, encompassing 452 patients. Fixed-effects models were applied to calculate aggregated hazard ratios (HRs) for overall survival (OS). Kaplan–Meier curves were analyzed using the Tierney method, and Trial Sequential Analysis (TSA) was performed to assess statistical power. Low miR-375 expression was associated with poorer OS, with an aggregated HR of 1.23 (95% CI: 1.10–1.37). Subgroup analysis showed consistent trends across oral and laryngeal squamous cell carcinoma. Sensitivity analysis confirmed these findings. TSA revealed that although the number of patients was sufficient, statistical power was insufficient to confirm a predefined risk reduction ratio (RRR) of 49%. Data from the TGCA cohort supported the meta-analysis findings, with an HR for OS of 1.32 (95% CI: 0.96–1.8). Low miR-375 expression is associated with worse survival outcomes in HNSCC patients, indicating its potential as a prognostic biomarker and therapeutic target. However, the retrospective nature of the included studies underscores the need for prospective research to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsSquamous Cell Carcinoma of Head and NeckBiomarkers, TumorHead and Neck NeoplasmsHumansPrognosisGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

head and neck squamous cell carcinomalaryngeal squamous cell carcinomamiR-375microRNAnon-coding RNAoral canceroral squamous cell carcinomaoropharyngeal squamous cell carcinoma

Substanzen

MicroRNAsMIRN375 microRNA, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122 Foggia, Italy.
  • DataLab, Department of Engineering for Innovation, University of Salento, 73100 Lecce, Italy.
  • Department of Precision Medicine, University of Campania Luigi Vanvitelli, Via De Crecchio, 7, 80138 Naples, Italy.

ORCID-Profile: Mario Dioguardi, Gennaro Musella, Pietro Laterza, Angelo Martella, Lorenzo Lo Muzio, Stefania Cantore, Andrea Ballini

Förderung

  • European Union-NextGeneration EU, PNRR - M4C2-I1.3"HEALTH EXTENDED ALLIANCE FOR INNOVATIVE THERAPIES, AD-VANCED LAB-RE-SEARCH, AND INTEGRATED APPROACHES OF PRE…
  • European Union-NextGeneration EU

Zitieren

APA

Dioguardi, M., Musella, G., Bizzoca, M. E., Sovereto, D., Guerra, C., Laterza, P., Martella, A., Lo Muzio, L., Di Domenico, M., Cantore, S., & Ballini, A. (2025). The Prognostic Role of miR-375 in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. International Journal of Molecular Sciences, 26(5), 2183. https://doi.org/10.3390/ijms26052183

Vancouver

Dioguardi M, Musella G, Bizzoca ME, Sovereto D, Guerra C, Laterza P, et al. The Prognostic Role of miR-375 in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. International Journal of Molecular Sciences. 2025;26(5):2183. doi:10.3390/ijms26052183

BibTeX
@article{Dioguardi2025,
  author = {Dioguardi, Mario and Musella, Gennaro and Bizzoca, Maria Eleonora and Sovereto, Diego and Guerra, Ciro and Laterza, Pietro and Martella, Angelo and Lo Muzio, Lorenzo and Di Domenico, Marina and Cantore, Stefania and Ballini, Andrea},
  title = {The Prognostic Role of miR-375 in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {2183},
  doi = {10.3390/ijms26052183}
}
Kostenlos starten →